Skip to content

Legal status · United States

Is Young Plasma Infusion legal in the United States?

Written by Reviewed Sep 2026

ApprovedLongevityStudies in people cited: 3

Direct answer

Yes. Young Plasma Infusion is an approved medicine in the United States. Its legal category is "Licensed blood product; giving it by drip for ageing is an unapproved use". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

People given it
18
Found nothing
0

Legal category

Licensed blood product; giving it by drip for ageing is an unapproved use

On 19 February 2019 the FDA told the public to be careful of places selling drips of plasma from young donors.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Young Plasma Infusion in the United States at a glance

Legal categoryLicensed blood product; giving it by drip for ageing is an unapproved use
NoteOn 19 February 2019 the FDA told the public to be careful of places selling drips of plasma from young donors.
FDA approval statusPlasma, the liquid part of blood, is a licensed blood product. Doctors use it for set medical reasons, such as blood clotting problems and plasma exchange. Giving it by drip for ageing, memory loss or diseases that kill brain cells is not an approved use. The FDA warned the public about clinics selling it on 19 February 2019.
Studies in people3 of 6 sources on the profile
ReviewedSep 2026

The legal category and note come from the Young Plasma Infusion profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.

What this means

  • 01

    FDA has approved Young Plasma Infusion for at least one use named on its label. So a proper pharmacy-grade product exists in the United States, and pharmacies hand it out on prescription.

  • 02

    Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.

  • 03

    Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.

What Young Plasma Infusion is

Plasma from donors aged 18 to 30, dripped into older people. The one proper trial took 18 people with Alzheimer disease and was built to check safety, not benefit. The FDA published a public warning about clinics selling it in February 2019.

The one proper trial was the PLASMA study at Stanford. It took 18 people with probable mild to moderate Alzheimer disease.

How it works: Not worked out in people. In mice, plasma from young animals carries factors including TIMP2, platelet factor 4, Gpld1 and clusterin.

Approval history: Plasma, the liquid part of blood, is a licensed blood product. Doctors use it for set medical reasons, such as blood clotting problems and plasma exchange. Giving it by drip for ageing, memory loss or diseases that kill brain cells is not an approved use. The FDA warned the public about clinics selling it on 19 February 2019.

How FDA treats this kind of product

Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.

The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Young Plasma Infusion on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check FDA directly

Young Plasma Infusion in sport and the military

Whether Young Plasma Infusion is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Young Plasma Infusion by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Young Plasma Infusion in other countries

Frequently asked questions

Is Young Plasma Infusion legal in the United States?

Yes. Young Plasma Infusion is an approved medicine in the United States. Its legal category is "Licensed blood product; giving it by drip for ageing is an unapproved use". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile. Note: On 19 February 2019 the FDA told the public to be careful of places selling drips of plasma from young donors.

Can I buy Young Plasma Infusion in the United States?

Only with a prescription. In the United States, Young Plasma Infusion has the legal category "Licensed blood product; giving it by drip for ageing is an unapproved use". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: On 19 February 2019 the FDA told the public to be careful of places selling drips of plasma from young donors.

Is Young Plasma Infusion FDA approved?

Yes. FDA status: Plasma, the liquid part of blood, is a licensed blood product. Doctors use it for set medical reasons, such as blood clotting problems and plasma exchange. Giving it by drip for ageing, memory loss or diseases that kill brain cells is not an approved use. The FDA warned the public about clinics selling it on 19 February 2019.. Current US legal category: "Licensed blood product; giving it by drip for ageing is an unapproved use". On the evidence, 1 completed human trial is cited on its profile.

Related compounds in the United States

Full research profile

How Young Plasma Infusion works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Young Plasma Infusion profile

This page is general information about the legal status of Young Plasma Infusion in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.